| Ytd | -55.43% | |
| 1y | -58.45% |
| Open | 0.52 | Prev Close | 0.50 | Low | 0.47 | High | 0.52 | Mkt Cap | 7.75M |
| Vol | 75.09K | Avg Vol | 1.47M | EPS | -1.75 | P/E | N/A | Forward P/E | -0.39 |
| Beta | 1.41 | Short Ratio | 0.04 | Inst. Own | 11.12% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-19 | 50-d Avg | 0.55 | 200-d Avg | 0.76 | 1yr Est | 8.13 |
EVGN News
Vancouver, British Columbia--(Newsfile Corp. - September 14, 2026) - EverGen Infrastructure Corp. (T
Evogene Ltd. (NASDAQ: EVGN - Get Free Report) was the target of a large drop in short interest in Au
Company urges shareholders to evaluate the significant changes already implemented and vote FOR all
EverGen Infrastructure Corp. (EVGN:CA) Q2 2026 Earnings Call Transcript
VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Compan
VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Compan
EverGen Infrastructure Corp. (EVGN:CA) Shareholder/Analyst Call Prepared Remarks Transcript
Recommendations Reinforce Confidence in Evogene's Strategic Plan and Long-Term Value Creation Strate
Evogene Ltd. (EVGN) Q2 2026 Earnings Call Transcript
Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.13) per share which beat the analyst consensu
Company continues strategic transformation, initiated in 2025, into a focused, AI-driven computation
Zoom conference call scheduled for August 18, 2026, at 9:00 AM ET REHOVOT, Israel, Aug. 14, 2026 /PR
Gainers Jin Medical International (NASDAQ:ZJYL) stock rose 70.7% to $3.67 during Monday's pre-m
Evogene Ltd. (NASDAQ: EVGN - Get Free Report) shares crossed below its 200-day moving average during
Zoom conference call scheduled for August 18, 2026, 9:00 AM ET REHOVOT, Israel, July 30, 2026 /PRNew
Collaboration combines Evogene's AI-driven computational chemistry platform with ELEO's proprietary
Gainers Agape ATP (NASDAQ:ATPC) shares rose 17.5% to $2.96 during Wednesday's after-market sess
AgPlenus Ltd., a company developing novel, sustainable crop protection products and a subsidiary of
New AI model enables ChemPass AI for Ag™ to identify and prioritize antifungal molecules with a high
Gainers Virax Biolabs Group (NASDAQ:VRAX) shares rose 178.9% to $8.87 during Thursday's regular
Supporting Israel's Academic Innovation Ecosystem: BCDD to Provide World-Class Experimental Infrastr
VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Compan
Gainers Pulsenmore (NASDAQ:PLSM) stock increased by 152.0% to $8.59 during Wednesday's pre-mark
Integration of agentic computational systems enables the early-stage definition of key clinical and
Conference to be held in San Diego, CA, USA – June 22-25, 2026 REHOVOT, Israel, June 9, 2026 /PRNews
Study Results Demonstrated Favorable Safety Profile and Preliminary Signals of Clinical ActivityREHO
Evogene Ltd. ("Evogene") (NASDAQ:EVGN) (TASE: EVGN), a pioneering computational chemistry co
Study Results Demonstrated Favorable Safety Profile and Preliminary Signals of Clinical Activity REH
Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.60) per share which missed the analyst consen
Evogene Ltd. (NASDAQ:EVGN)(TASE: EVGN) (the "Company", "Evogene"), a pioneering comp
Updating on Strategic Progress and OutlookREHOVOT, Israel, Feb. 25, 2026 /PRNewswire/ -- Evogene Ltd
Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing
The collaboration is supported by a pan-European EUREKA grant, with participation of the Weizmann In
This announcement marks the second major milestone in the partnership between Evogene and Google Clo
BMC128 was developed by Biomica and is currently completing a Phase 1 clinical study, showing promis
Partnership addresses the unmet need for remyelination therapies for multiple sclerosis and other de
Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.31) per share which beat the analyst consensu
